Increased pressor sensitivity to chronic nitric oxide deficiency in hyperthyroid rats.

Area of Science:

• Cardiovascular Physiology
• Endocrinology
• Renal Physiology

Background:

• Thyroid hormones influence cardiovascular function and blood pressure regulation.
• Nitric oxide (NO) plays a crucial role in maintaining vascular tone and blood pressure.
• The interplay between thyroid status, NO, and blood pressure is not fully understood.

Purpose of the Study:

• To investigate the combined effects of thyroid hormone excess and partial nitric oxide deficiency on blood pressure.
• To examine the role of the renin-angiotensin system (RAS) in the hypertension resulting from this interaction.
• To assess the impact on morphological, metabolic, plasma, and renal variables.

Main Methods:

• Male Wistar rats were divided into eight groups receiving thyroxine, Nw-nitro-L-arginine methyl ester (L-NAME), both, or neither, with or without losartan (RAS inhibitor).
• Treatments were administered for three weeks, with weekly blood pressure monitoring.
• Mean arterial pressure, morphological, metabolic, plasma, and renal variables were assessed post-treatment.

Main Results:

• Thyroxine alone caused a mild increase in blood pressure and elevated plasma angiotensin II and nitrates/nitrites.
• Combined thyroxine and L-NAME administration resulted in a significant and marked increase in blood pressure.
• Losartan normalized blood pressure in thyroxine-treated rats and attenuated the elevation in thyroxine+L-NAME rats, but did not alter organ hypertrophy or proteinuria.

Conclusions:

• Impaired nitric oxide availability may counteract the blood pressure-raising effects of thyroid hormone excess.
• The renin-angiotensin system is critical for the hypertension observed in rats with combined thyroid hormone excess and nitric oxide deficiency.
• The observed renal and ventricular hypertrophy and proteinuria in hyperthyroid rats are independent of the renin-angiotensin system.